RTL9
gene geneOn this page
Also known as KIAA1318Mart9Mar9SIRH10
Summary
RTL9 (retrotransposon Gag like 9, HGNC:29245) is a protein-coding gene on chromosome Xq23, encoding Retrotransposon Gag-like protein 9 (Q8NET4).
At a glance
- Clinical variants (ClinVar): 221 total
- MANE Select transcript:
NM_001385449
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29245 |
| Approved symbol | RTL9 |
| Name | retrotransposon Gag like 9 |
| Location | Xq23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1318, Mart9, Mar9, SIRH10 |
| Ensembl gene | ENSG00000243978 |
| Ensembl biotype | protein_coding |
| OMIM | 300965 |
| Entrez | 57529 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000465301, ENST00000520821, ENST00000540313
RefSeq mRNA: 2 — MANE Select: NM_001385449
NM_001385449, NM_020769
CCDS: CCDS14552
Canonical transcript exons
ENST00000520821 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002110296 | 110450567 | 110454664 |
| ENSE00002123383 | 110445153 | 110445268 |
| ENSE00003967359 | 110455202 | 110456334 |
| ENSE00003967360 | 110358848 | 110358916 |
Expression profiles
Bgee: expression breadth broad, 83 present calls, max score 77.55.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0735 / max 52.7769, expressed in 14 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 197266 | 0.0466 | 9 |
| 197265 | 0.0205 | 4 |
| 197264 | 0.0064 | 3 |
Top tissues by expression
215 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 77.55 | silver quality |
| right testis | UBERON:0004534 | 74.82 | gold quality |
| left testis | UBERON:0004533 | 72.19 | gold quality |
| testis | UBERON:0000473 | 72.10 | gold quality |
| pancreatic ductal cell | CL:0002079 | 69.01 | silver quality |
| ventricular zone | UBERON:0003053 | 66.84 | gold quality |
| ileal mucosa | UBERON:0000331 | 64.56 | silver quality |
| cortical plate | UBERON:0005343 | 63.02 | gold quality |
| deltoid | UBERON:0001476 | 62.59 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 60.77 | gold quality |
| lower lobe of lung | UBERON:0008949 | 57.87 | silver quality |
| ganglionic eminence | UBERON:0004023 | 57.08 | gold quality |
| adrenal tissue | UBERON:0018303 | 57.07 | gold quality |
| hypothalamus | UBERON:0001898 | 57.00 | gold quality |
| adult organism | UBERON:0007023 | 57.00 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 55.74 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 55.53 | gold quality |
| nucleus accumbens | UBERON:0001882 | 55.31 | gold quality |
| heart left ventricle | UBERON:0002084 | 54.61 | gold quality |
| right ovary | UBERON:0002118 | 54.44 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 54.23 | gold quality |
| cardiac ventricle | UBERON:0002082 | 54.12 | gold quality |
| kidney epithelium | UBERON:0004819 | 53.93 | gold quality |
| left ovary | UBERON:0002119 | 53.89 | gold quality |
| upper arm skin | UBERON:0004263 | 53.52 | gold quality |
| oocyte | CL:0000023 | 53.42 | gold quality |
| ovary | UBERON:0000992 | 52.84 | gold quality |
| prefrontal cortex | UBERON:0000451 | 52.71 | gold quality |
| substantia nigra | UBERON:0002038 | 51.21 | gold quality |
| heart | UBERON:0000948 | 50.92 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.61 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
92 targeting RTL9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-6759-5P | 99.99 | 66.54 | 785 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-141-3P | 99.94 | 72.79 | 2421 |
| HSA-MIR-200A-3P | 99.94 | 72.68 | 2420 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-206 | 99.93 | 72.50 | 1893 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-1-3P | 99.93 | 72.35 | 1914 |
| HSA-MIR-219A-5P | 99.91 | 73.36 | 735 |
Cross-species orthologs
7 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | vap | ENSDARG00000088975 |
| mus_musculus | Rtl9 | ENSMUSG00000085584 |
| rattus_norvegicus | Rtl9 | ENSRNOG00000049853 |
| drosophila_melanogaster | mesh | FBGN0051004 |
| caenorhabditis_elegans | WBGENE00010047 | |
| caenorhabditis_elegans | WBGENE00010540 | |
| caenorhabditis_elegans | WBGENE00011175 |
Paralogs (2): SUSD2 (ENSG00000099994), MUC4 (ENSG00000145113)
Protein
Protein identifiers
Retrotransposon Gag-like protein 9 — Q8NET4 (reviewed: Q8NET4)
Alternative names: Retrotransposon gag domain-containing protein 1, Tumor antigen BJ-HCC-23
All UniProt accessions (2): E5RKA1, Q8NET4
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. RTL9 is one of at least 11 genes called Mar or Mart related to long terminal repeat retrotransposons. They do not correspond to functional retrotransposons, but rather to neofunctionalized retrotransposons genes.
RefSeq proteins (2): NP_001372378, NP_065820 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR042919 | RTL9 | Family |
UniProt features (9 total): region of interest 5, compositionally biased region 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NET4-F1 | 39.37 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 103 (showing top):
GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, RNGTGGGC_UNKNOWN, MYAATNNNNNNNGGC_UNKNOWN, AP1_01, FREAC2_01, HNF3ALPHA_Q6, GGGNRMNNYCAT_UNKNOWN, RORA1_01, FOXO4_01, FOXO1_01, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, CAGCTG_AP4_Q5, FOXD3_01, AP1_Q4_01, HEN1_01
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
718 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RTL9 | RTL6 | Q6ICC9 | 810 |
| RTL9 | RTL4 | Q6ZR62 | 716 |
| RTL9 | NUTM2G | Q5VZR2 | 664 |
| RTL9 | RTL8C | A6ZKI3 | 606 |
| RTL9 | AMMECR1 | Q9Y4X0 | 600 |
| RTL9 | LDOC1 | O95751 | 599 |
| RTL9 | TMEM164 | Q5U3C3 | 578 |
| RTL9 | NUGGC | Q68CJ6 | 541 |
| RTL9 | MAP7D2 | Q96T17 | 505 |
| RTL9 | RALGPS1 | Q5JS13 | 486 |
| RTL9 | APOLD1 | Q96LR9 | 424 |
| RTL9 | RTL5 | Q5HYW3 | 416 |
| RTL9 | ZCCHC3 | Q9NUD5 | 402 |
| RTL9 | ZC3H7B | Q9UGR2 | 400 |
| RTL9 | RTL1 | A6NKG5 | 398 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSF1 | KPNA3 | psi-mi:“MI:0914”(association) | 0.640 |
| CBX6 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.530 |
| PRDX2 | PRDX3 | psi-mi:“MI:0914”(association) | 0.510 |
| ANKRA2 | RTL9 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| CIMIP4 | ATE1 | psi-mi:“MI:0914”(association) | 0.350 |
| UGT1A7 | FGFR1 | psi-mi:“MI:0914”(association) | 0.350 |
| UGT1A7 | ADAM10 | psi-mi:“MI:0914”(association) | 0.350 |
| CD247 | DDX1 | psi-mi:“MI:0914”(association) | 0.350 |
| CEP152 | CNOT1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| RTL9 | HSF1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRDX2 | RTL9 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (12): RGAG1 (Proximity Label-MS), RGAG1 (Proximity Label-MS), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), HSF1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), NASP (Cross-Linking-MS (XL-MS)), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS)
ESM2 similar proteins: A0A0U1RQI7, A0A494C071, A6QL64, A6ZXT5, A7XUY5, E2RYF6, E2RYF7, O60732, O88799, P06916, P12021, P18583, P41809, P43537, P47179, P53353, Q00130, Q02496, Q02505, Q04893, Q05049, Q12459, Q14242, Q32KG4, Q4ZJY7, Q4ZJZ0, Q54QZ8, Q5H9R4, Q5H9T9, Q5JPF3, Q5SSG8, Q5XHX6, Q60528, Q63661, Q685J3, Q6P902, Q86VQ3, Q8JZM8, Q8N307, Q8NET4
Diamond homologs: Q32KG4, Q8NET4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
221 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 168 |
| Likely benign | 14 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
716 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:110419132:GTGG:G | donor_gain | 1.0000 |
| X:110419133:TGGG:T | donor_loss | 1.0000 |
| X:110419134:GG:G | donor_gain | 1.0000 |
| X:110419135:GG:G | donor_gain | 1.0000 |
| X:110419136:G:GA | donor_loss | 1.0000 |
| X:110445110:T:TA | acceptor_gain | 1.0000 |
| X:110419133:TGG:T | donor_gain | 0.9900 |
| X:110419134:GGG:G | donor_gain | 0.9900 |
| X:110419136:G:GG | donor_gain | 0.9900 |
| X:110454599:GCCT:G | donor_gain | 0.9900 |
| X:110455194:A:AG | acceptor_gain | 0.9900 |
| X:110455197:CCCA:C | acceptor_loss | 0.9900 |
| X:110455198:CCA:C | acceptor_loss | 0.9900 |
| X:110455200:A:AG | acceptor_gain | 0.9900 |
| X:110455200:A:AT | acceptor_loss | 0.9900 |
| X:110455201:G:A | acceptor_loss | 0.9900 |
| X:110455201:G:GA | acceptor_gain | 0.9900 |
| X:110455201:GC:G | acceptor_gain | 0.9900 |
| X:110455201:GCACC:G | acceptor_gain | 0.9900 |
| X:110445111:G:A | acceptor_gain | 0.9800 |
| X:110454662:G:GT | donor_gain | 0.9800 |
| X:110455195:C:G | acceptor_gain | 0.9800 |
| X:110419131:TGTGG:T | donor_gain | 0.9700 |
| X:110419132:GTGGG:G | donor_gain | 0.9700 |
| X:110419133:TGGGT:T | donor_gain | 0.9700 |
| X:110445147:T:G | acceptor_gain | 0.9700 |
| X:110454620:G:GT | donor_gain | 0.9700 |
| X:110455201:GCA:G | acceptor_gain | 0.9700 |
| X:110455201:GCAC:G | acceptor_gain | 0.9700 |
| X:110444492:T:TA | donor_gain | 0.9600 |
AlphaMissense
558 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:110450645:T:C | F10L | 0.758 |
| X:110450647:C:A | F10L | 0.758 |
| X:110450647:C:G | F10L | 0.758 |
| X:110450828:T:C | F71L | 0.717 |
| X:110450830:T:A | F71L | 0.717 |
| X:110450830:T:G | F71L | 0.717 |
| X:110450699:T:C | F28L | 0.662 |
| X:110450701:C:A | F28L | 0.662 |
| X:110450701:C:G | F28L | 0.662 |
dbSNP variants (sampled 300 via entrez): RS1000053110 (X:110362214 C>G,T), RS1000103740 (X:110361767 A>T), RS1000103882 (X:110423688 T>G), RS1000164254 (X:110445362 A>G), RS1000169722 (X:110421267 G>A), RS1000279452 (X:110371401 A>G), RS1000421008 (X:110360224 C>G), RS1000476139 (X:110424177 A>G), RS1000489570 (X:110445776 G>A), RS1000501363 (X:110448302 C>T), RS1000542869 (X:110395351 C>T), RS1000595426 (X:110372130 G>A,T), RS1000599925 (X:110386136 G>T), RS1000679670 (X:110363173 T>C), RS1000682331 (X:110436682 C>T)
Disease associations
OMIM: gene MIM:300965 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2,4,6-tribromophenol | decreases expression | 1 |
| methyleugenol | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| tetrabromobisphenol A | decreases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment | 1 |
| 2,2’,4,4’-tetrabromodiphenyl ether | decreases expression | 1 |
| pentabrominated diphenyl ether 100 | increases expression | 1 |
| hexabrominated diphenyl ether 153 | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Caffeine | increases phosphorylation | 1 |
| Cisplatin | increases expression | 1 |
| Estradiol | increases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Lipopolysaccharides | increases expression, affects response to substance, affects cotreatment | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| N-Nitrosopyrrolidine | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| S-Nitrosoglutathione | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.